Ethyl 2-(2,4-difluorophenyl)-2,2-difluoroacetate, 95.0%, 1g

Sodium hydroxide solution 0.5%, 0.5%, extra pure, 1 l, plastic packaging.

(2S)-2-methoxy-1-propanol, 95.0%, 1g

1-(2,2-Difluoroethyl)-1H-pyrazol-4-amine, 97%, 250mg

REPARIXIN, 95%, 5mg

3,6,9,12-Tetraoxatetradecane-1,14-diol, 1-4-methylbenzenesulfonate, 98%, 500mg

[S(R)]-N-[(R)-[4-(1,1-Dimethylethyl)phenyl][5-(diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl]methyl]-2-methyl-2-propanesulfinamide, 95%, 100mg

N-o-Tolylformamide, 95.0%, 1g

(R)-(-)-alpha-[[(4-Ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]benzeneacetic Acid>98.0%(HPLC)(T)1g

(E)-1-Chloro-3,7-dimethylocta-2,6-diene, 95.0%, 5g

(6,7-dihydro-5H-cyclopenta[d]pyrimidin-2-ylmethyl)amine dihydrochloride, 95.0%, 250mg

(2S,4R)-1-((S)-2-AMINO-3,3-DIMETHYLBUTANOYL)-4-HYDROXY-N-(4-(4-METHYLTHIAZOL-5-YL)BENZYL)PYRROLIDINE-2-CARBOXAMIDE, 95%, 10g

tert-Butyl 4-(hydroxymethyl)benzoate, 95.0%, 250mg